Medication-Assisted Treatment for Addiction Recovery

Recovery from alcohol or opioid use disorder is rarely supported by one intervention alone. The most effective care addresses cravings, withdrawal risks, mental health, daily routines, and the circumstances that make sustained recovery possible.

Medication selection is only one part of safe care. A qualified medical team evaluates the whole person, including co-occurring mental health needs and patient body weight when determining medication dosing during detoxification or stabilization. Understanding how this integrated model works makes it easier to evaluate treatment options and ask informed questions about the care ahead.

Verify your insurance or call 513-586-4971 to learn how physician-led medication-assisted treatment can be built around your recovery goals.

What Is Medication-Assisted Treatment?

MAT is a clinical approach for substance use disorders that combines an FDA-approved medication with counseling and behavioral therapy. Medication can reduce cravings, withdrawal symptoms, or the effects of certain substances, while therapy helps a person address the patterns, stressors, and health concerns that support lasting recovery. The treatment plan is tailored to the individual rather than built around a one-size-fits-all prescription.

For opioid use disorder, research describes MAT as the pairing of psychosocial intervention with an FDA-approved medication. This combined model recognizes that substance use disorders affect both physical and behavioral health. Medication may stabilize the body enough for a person to participate meaningfully in counseling, while therapy supports decision-making, coping skills, relationships, and long-term recovery planning. Research on MAT for opioid use disorder has associated the approach with reductions in overdose deaths, criminal activity, and infectious disease transmission.

Who Can Benefit From MAT?

MAT may benefit people living with opioid or alcohol use disorders, including those who have experienced repeated relapse, intense cravings, difficult withdrawal, or an overdose risk. A medical professional determines whether MAT is appropriate after reviewing substance use, medical history, current symptoms, medications, and recovery goals. The clinician may also recommend counseling, psychiatric care, family support, or other services as part of a whole-person plan.

Safe medication selection requires individualized clinical review. During detoxification or stabilization, the medical team must consider patient body weight when selecting medications and determining appropriate doses. Other factors, including health conditions and possible medication interactions, also influence the plan. This careful process helps clinicians balance symptom relief, safety, and the person’s ability to engage in treatment.

MAT is therefore one component of comprehensive care, not a replacement for therapy or a standalone solution. People seeking coordinated support can explore comprehensive medication-assisted treatment programs that connect medical oversight with behavioral health services and ongoing recovery support.

FDA-Approved Medications Used in MAT

The Food and Drug Administration has approved several medications for substance use disorders. But the right option depends on the substance involved, current withdrawal status, medical history, and treatment goals. Medication selection is a clinical decision, not a one-size-fits-all choice. The FDA explains that medications for opioid use disorder should be provided as part of comprehensive care and ongoing medical supervision.

Naltrexone

Naltrexone blocks opioid receptors, which can reduce opioid cravings and block the euphoric and sedative effects of opioids. It is approved for both opioid use disorder and alcohol use disorder. Naltrexone is not an opioid, is non-addictive, and does not cause withdrawal when discontinued. Depending on the treatment plan. It may be prescribed as a daily pill for alcohol use disorder or as an extended-release intramuscular injection for alcohol or opioid use disorder. Before starting naltrexone for opioid use disorder. A person generally must remain opioid-free for at least 7 days after short-acting opioids or 10 to 14 days after long-acting opioids to reduce the risk of precipitated withdrawal. Learn more from SAMHSA’s naltrexone guidance.

Buprenorphine

Buprenorphine is used for opioid use disorder. It reduces cravings and withdrawal symptoms, helping create enough stability for a person to participate in counseling, address triggers, and build recovery skills. Because it is an opioid medication with specific safety considerations, a qualified clinician should determine when and how to begin it. SAMHSA’s buprenorphine guidance provides additional information about its role in treatment.

Acamprosate

Acamprosate is approved for alcohol use disorder. It may reduce alcohol cravings by helping restore the neurotransmitter balance disrupted by chronic alcohol use. Clinicians usually start it a few days after alcohol use has stopped and most withdrawal symptoms have subsided. Acamprosate has no potential for misuse and is considered safe to use with psychiatric medications, although severe kidney disease requires careful evaluation. Review SAMHSA’s acamprosate guidance for more detail.

During detoxification and stabilization, the medical team also considers patient body weight when selecting and dosing medication. A complete assessment helps clinicians account for kidney or liver concerns, other prescriptions, psychiatric medications, and withdrawal risk before creating an individualized MAT plan.

How MAT Works With Counseling and Behavioral Therapy

Medication-Assisted Treatment (MAT) works best as part of a coordinated plan rather than as a medication-only service. Medication can reduce the physical intensity of cravings and withdrawal, giving a person more stability during early recovery. Counseling and behavioral therapy then help address the thoughts, emotions, habits, and relationship patterns that can sustain substance use.

This division of support allows treatment to address both the physiological and behavioral sides of a substance use disorder. A medical professional selects and adjusts medication based on the person’s diagnosis, health history, response, and treatment goals. The therapy team can then help the person recognize triggers, practice healthier responses, and build a recovery routine that remains useful outside of treatment.

What counseling adds to medication support

Behavioral therapy gives patients practical tools for managing the situations that medication cannot resolve by itself. Cognitive behavioral therapy can help identify unhelpful thought patterns and replace them with more constructive choices. Dialectical behavior therapy may support emotional regulation, distress tolerance, and interpersonal skills. Motivational interviewing can help a person explore ambivalence about change without judgment, while trauma-informed care keeps treatment attentive to safety, trust, and the effects of past experiences.

Supportive counseling also provides a consistent place to discuss cravings, setbacks, progress, and changes in daily life. The goal is not to pressure someone into a perfect recovery process. It is to strengthen insight and coping skills while the medical plan reduces barriers to participation. This integrated model is consistent with the whole-person treatment approach described by SAMHSA, which includes counseling and behavioral health therapies alongside medication.

Why monitoring matters during recovery

MAT plans require ongoing communication with the treating practitioner. Medication needs can change as withdrawal symptoms ease, cravings shift, or a person’s health and recovery environment develop. Supportive counseling and long-term practitioner monitoring can increase the effectiveness of treatment by allowing the care team to respond to those changes instead of relying on a fixed plan.

Monitoring also helps the team coordinate medication with therapy and identify concerns early. Patients should share all prescribed medications, supplements, and relevant mental health symptoms with their providers. A plan that includes both medical and behavioral support can be especially important for people who need dual diagnosis treatment. Legacy Healing Center emphasizes integrated care for co-occurring mental health and substance use disorders, so psychiatric and addiction-related needs can be addressed together.

MAT and psychiatric medications

For people living with a co-occurring mental health condition, receiving MAT does not automatically mean psychiatric treatment must stop. SAMHSA notes that acamprosate is safe to use in combination with psychiatric medications. The broader lesson is that medication combinations require individualized clinical review. Providers should evaluate the person’s current medications, health conditions, and response to treatment before recommending a specific option or dosage.

When medical care, counseling, behavioral therapy, and psychiatric support work from the same plan, recovery can become more stable and more practical. MAT helps create the physiological foundation for participation, while therapy helps patients develop the skills and understanding needed to sustain change.

What Medication-Assisted Treatment Looks Like at Legacy Healing Center

At Legacy Healing Center, Medication-Assisted Treatment (MAT) is delivered through physician-led, individualized care rather than a one-size-fits-all protocol. Medical treatment is coordinated with counseling, behavioral health support, and the practical structure people need to begin recovery safely.

Physician-Led Medical Oversight

Dr. Ash Bhatt, Legacy Healing Center’s chief medical officer, is a quintuple board-certified addiction psychiatrist who oversees medical protocols across treatment programs. His oversight supports a coordinated plan for addiction, mental health, and physical health needs. This physician-led model is especially important during detox and stabilization, when symptoms, medication response, and safety can change quickly.

Care may begin with medically supervised detox and continue through the center’s vertically integrated treatment continuum. As the patient’s condition changes, the clinical team can adjust the plan while maintaining continuity between medical care, therapy, and recovery planning.

Individualized Dosing and Monitoring

Medication selection and dosing require more than knowing which substance a person has used. Legacy’s medical team requires the patient’s body weight to determine proper medication dosing during detox and stabilization. Patient body weight is a mandatory clinical consideration in these protocols because accurate dosing supports safer, more individualized medical care.

The team also considers the patient’s substance use history, current symptoms, medical conditions, psychiatric medications, and response to treatment. For example, practitioners must review potential medication interactions, and certain medications require attention to liver or kidney health. These decisions belong with qualified medical professionals who can evaluate the full clinical picture.

MAT remains one part of whole-person treatment. Supportive counseling and ongoing practitioner monitoring help patients address cravings, withdrawal concerns, emotional health, and the behaviors connected to substance use. Families or individuals who want to understand potential next steps can verify your insurance before speaking with the admissions team about an individualized plan.

How Long Does MAT Take and Does It Work?

There is no single timeline for MAT. Treatment commonly continues for several months, with medication, supportive counseling, and regular monitoring adjusted as recovery progresses. Some people need longer support, especially when opioid use disorder, alcohol use disorder, medical conditions, or co-occurring mental health concerns affect stabilization. The goal is not to rush medication discontinuation. It is to create enough stability for safer detox, clearer decision-making, and sustained participation in recovery care.

What to Expect During MAT

Before medication begins, a clinician completes a thorough medical assessment. This review may include substance use history, current medications and supplements, liver health, kidney function, psychiatric needs, and patient body weight. Weight is a mandatory clinical consideration for medication selection and dosing during detox and stabilization. Screening also helps the medical team identify interactions and determine whether a medication is appropriate for the individual.

1. A physician completes an initial medical and psychiatric assessment and confirms which substance use disorder and co-occurring conditions are present.
2. The care team reviews medical history, current medications, laboratory results, and patient body weight to guide medication selection and appropriate dosing.
3. The physician starts the chosen medication during detoxification or stabilization and monitors response, cravings, and withdrawal symptoms closely.
4. Counseling and behavioral therapy run alongside the medication plan, with the team adjusting treatment as symptoms, health, and recovery goals change.

Naltrexone requires particular timing for people transitioning from opioids. Patients generally need to remain opioid-free for at least 7 days after short-acting opioids and 10 to 14 days after long-acting opioids before starting it. Beginning too soon can trigger withdrawal, so this step must follow physician guidance and an individualized assessment. The SAMHSA naltrexone guidance explains this opioid-free window and other safety considerations.

For alcohol use disorder, acamprosate is typically started a few days after alcohol use stops, once most withdrawal symptoms have subsided. It should not be started by people with severe kidney disease, and liver health, other medications, and overall medical history still matter when selecting a treatment plan. SAMHSA’s acamprosate guidance outlines these considerations.

Does MAT Work for Opioid Use Disorder?

Evidence supports MAT as a medically managed approach for opioid use disorder. Research has associated MAT with reductions in overdose deaths, criminal activity, and infectious disease transmission. These outcomes reflect more than the medication alone. Ongoing clinical monitoring, counseling, and practical recovery support help patients remain engaged while cravings and withdrawal symptoms become more manageable. A review published in PubMed Central summarizes these outcomes.

Progress is measured through safety, reduced cravings, improved functioning, and consistent engagement in care, not simply by how quickly medication ends. A physician-led team can reassess the plan as health, symptoms, and recovery goals change.

Ready to explore medication-assisted treatment? Verify your insurance or call 513-586-4971 to speak with the admissions team today.

Frequently Asked Questions

Is MAT substituting one addiction for another?

No. The medications used in MAT are selected for specific clinical purposes, such as reducing cravings, easing withdrawal symptoms, or blocking opioid effects. A physician monitors the response, adjusts treatment safely, and pairs medication with counseling and behavioral therapy rather than replacing recovery work with a prescription. Naltrexone is not an opioid and is not addictive, according to SAMHSA.

Which medications can be used for alcohol or opioid use disorders?

Naltrexone may treat both alcohol use disorder and opioid use disorder. Acamprosate supports abstinence from alcohol, while buprenorphine reduces cravings and withdrawal symptoms associated with opioid use disorder. The appropriate option depends on medical history, current substance use, treatment goals, and potential medication interactions.

Does MAT work for alcohol use disorder?

It can be an effective part of treatment when combined with supportive counseling and ongoing monitoring. Acamprosate is generally started a few days after alcohol use stops and withdrawal symptoms have subsided. Naltrexone may also be appropriate for some patients, but a clinician should review liver health, other medications, and whether opioids are present before prescribing.

How does a physician choose the right medication?

A physician reviews substance-use history, withdrawal risk, psychiatric and medical conditions, current medications, and laboratory findings. During detox and stabilization at Legacy Healing Center, the medical team also requires patient body weight for proper medication selection and dosing. This individualized review helps support safer, more comfortable care.

Ready to Take the Next Step?

Medication-assisted treatment can provide structured medical support while counseling and behavioral therapy address the deeper patterns behind substance use. A personalized evaluation helps the care team determine whether this approach fits your needs and recovery goals. Verify your insurance with Legacy Healing Center, then talk with the admissions team about starting physician-led care. Call 513-586-4971 to speak with the team today.